Monte Rosa Therapeutics
GLUE
GLUE
71 hedge funds and large institutions have $227M invested in Monte Rosa Therapeutics in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
4.9% less ownership
Funds ownership: 85.14% → 80.24% (-4.9%)
40% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 25
Holders
71
Holding in Top 10
2
Calls
$2.9M
Puts
$1.24M
Top Buyers
| 1 | +$6.05M | |
| 2 | +$865K | |
| 3 | +$717K | |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$512K |
| 5 |
Jane Street
New York
|
+$400K |
Top Sellers
| 1 | -$7.47M | |
| 2 | -$3.89M | |
| 3 | -$2.64M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$2.2M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$899K |